Latest From Biotech Now

Integrating the Patient Voice: Recap of the 2016 BIO CEO & Investor Conference

CEO2013_115x75_Thumbnail copy

The 2016 BIO CEO & Investor Conference isn’t just for biotech companies and the investment community, the conference featured a strong patient voice and focus on the patient perspective in drug development and drug delivery. Two of the most highly-attended panel discussions were moderated by patient advocates. On Monday, Sue Peschin, President & Chief Executive Officer, Alliance for Aging Research, led a timely panel discussion with clinical researchers and biotech CEOs around the recent positive Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Water: Why The Most Basic Resource Needs Our Attention

GMO Answers

Water is on everyone’s mind lately. From the California drought to the Flint water crisis, it’s clear that our water is in jeopardy.  In spite of pollution and waste, we can still maintain the health and safety of our water supply. GMO Answers Forbes blog recently posted a great piece by Kate Hall, managing director of the Council for Biotechnology Information and GMO Answers spokesperson, which looks at this issue. In her piece “Water: Why The Most Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

#BIOCEO16 Session Recap: Regulatory Policy Outlook—PDUFA VI and You

CEO2013_115x75_Thumbnail copy

The second day of #BIOCEO16 kicked off this morning with a look ahead to PDUFA VI and potential ways to improve the drug development and approval process. Moderated by BIO Executive Vice President of Emerging Companies Cartier Esham, the panelists included: Elizabeth Krutoholow, Analyst, Bloomberg Intelligence Jonathan Leff, Partner, Deerfield Management; Chairman, Deerfield Institute Richard F. Pops, Chairman & Chief Executive Officer, Alkermes The challenges and opportunities presented by the growing amount of available “real Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Samuel Isaly: Anticipate the Anticipators

Isaly_CEOPanel

Samuel Isaly, Managing Partner of OrbiMed Advisors, joined BIO CEO & Investor Conference attendees for a Fireside Chat, moderated by David Gluckman, Co-Head of the Global Healthcare Group at Lazard.  The discussion called upon Isaly’s wealth of healthcare and pharmaceutical knowledge spanning nearly 50 years, focusing on the value of innovation. OrbiMed has a simple “secret sauce” to their success, they only employ bright, hardworking, honest and lucky people to manage their funds.  As a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Jim Greenwood on “Time is Precious”

TimeIsPrecious_ScreenCap

Jim Greenwood, President & CEO, Biotechnology Innovation Organization discusses the organizations new campaign, Time is Precious. Greenwood says, “… if we are going to continue to create new treatments and cures we are going to have to continue to invest and attract investment capital.”  Watch the full interview below.

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,